Skip to main content
SpringerLink
Log in
Book cover

COPD pp 1–20Cite as

The Multiple Components of COPD

  • Chapter
  • First Online:

Part of the book series: Respiratory Medicine ((RM))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J (2007) Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176(6):532–555

    Article  PubMed  Google Scholar 

  2. Celli BR, Snider GL, Heffner J, Tiep B, Ziment I, Make B, Braman S, Olsen G, Philips Y (1995) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 152(5 Pt 2):S77–S121

    Google Scholar 

  3. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350(26):2645–2653

    Article  CAS  PubMed  Google Scholar 

  4. Cosio MG, Saetta M, Agusti A (2009) Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 360(23):2445–2454

    Article  CAS  PubMed  Google Scholar 

  5. Barnes PJ, Shapiro SD, Pauwels RA (2003) Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 22(4):672–688

    Article  CAS  PubMed  Google Scholar 

  6. MacNee W (2005) Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2(1):50–60

    Article  CAS  PubMed  Google Scholar 

  7. Agusti AG (2005) Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2(4):367–370, discussion 371–2

    Article  PubMed  Google Scholar 

  8. Barnes PJ, Celli BR (2009) Systemic manifestations and comorbidities of COPD. Eur Respir J 33(5):1165–1185

    Article  CAS  PubMed  Google Scholar 

  9. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF (2007) Systemic effects of smoking. Chest 131(5):1557–1566

    Article  CAS  PubMed  Google Scholar 

  10. Vermeeren MA, Creutzberg EC, Schols AM, Postma DS, Pieters WR, Roldaan AC, Wouters EF (2006) Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med 100(8):1349–1355

    Article  CAS  PubMed  Google Scholar 

  11. Rutten EP, Franssen FM, Engelen MP, Wouters EF, Deutz NE, Schols AM (2006) Greater whole-body myofibrillar protein breakdown in cachectic patients with chronic obstructive pulmonary disease. Am J Clin Nutr 83(4):829–834

    CAS  PubMed  Google Scholar 

  12. Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, Wilkinson IB, Cockcroft JR, Shale DJ (2007) Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175:1259–1265

    Article  PubMed  Google Scholar 

  13. Sevenoaks MJ, Stockley RA (2006) Chronic obstructive pulmonary disease, inflammation and co-morbidity–a common inflammatory phenotype? Respir Res 7:70

    Article  PubMed  CAS  Google Scholar 

  14. Rutten FH, Cramer MJ, Zuithoff NP, Lammers JW, Verweij W, Grobbee DE, Hoes AW (2007) Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease. Eur J Heart Fail 9(6–7):651–659

    Article  CAS  PubMed  Google Scholar 

  15. Rutten FH, Moons KG, Cramer MJ, Grobbee DE, Zuithoff NP, Lammers JW, Hoes AW (2005) Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 331(7529):1379

    Article  PubMed  Google Scholar 

  16. Dahl M, Tybjaerg-Hansen A, Vestbo J, Lange P, Nordestgaard BG (2001) Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164(6):1008–1011

    CAS  PubMed  Google Scholar 

  17. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG (2007) C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175(3):250–255

    Article  CAS  PubMed  Google Scholar 

  18. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM (2001) Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163(6):1304–1309

    CAS  PubMed  Google Scholar 

  19. Global Initiative for Asthma (2002) Update of the NHLBI/WHO workshop report: global strategy for asthma management and prevention. Issued January 1995. National Institutes of Health, National Heart Lung and Blood Institute, Bethesda, MD, Document no. 02–3659

    Google Scholar 

  20. Gould GA, MacNee W, McLean A, Warren PM, Redpath A, Best JJ, Lamb D, Flenley DC (1988) CT measurements of lung density in life can quantitate distal airspace enlargement – an essential defining feature of human emphysema. Am Rev Respir Dis 137(2):380–392

    CAS  PubMed  Google Scholar 

  21. McLean A, Warren PM, Gillooly M, MacNee W, Lamb D (1992) Microscopic and macroscopic measurements of emphysema: relation to carbon monoxide gas transfer. Thorax 47(3):144–149

    Article  CAS  PubMed  Google Scholar 

  22. ÓShaughnessy TC, Ansari TW, Barnes NC, Jeffery PK (1997) Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med 155(3):852–857

    Google Scholar 

  23. Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM (1998) CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157(3 Pt 1):822–826

    CAS  PubMed  Google Scholar 

  24. Guerassimov A, Hoshino Y, Takubo Y, Turcotte A, Yamamoto M, Ghezzo H, Triantafillopoulos A, Whittaker K, Hoidal JR, Cosio MG (2004) The development of emphysema in cigarette smoke-exposed mice is strain dependent. Am J Respir Crit Care Med 170(9):974–980

    Article  PubMed  Google Scholar 

  25. Baraldo S, Saetta M, Cosio MG (2003) Pathophysiology of the small airways. Semin Respir Crit Care Med 24(5):465–472

    Article  PubMed  Google Scholar 

  26. Anthonisen NR, Wright EC (1986) Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis 133(5):814–819

    CAS  PubMed  Google Scholar 

  27. Chanez P, Vignola A, ÓShaughnessy T, Enander I, Li D, Jeffery P, Bousquet J (1997) Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med 155:1529–1534

    CAS  PubMed  Google Scholar 

  28. Enright P, Quanjer P (2007) Don’t diagnose mild COPD without confirming airway obstruction after an inhaled bronchodilator. COPD 4(2):89–90

    Article  PubMed  Google Scholar 

  29. Gross NJ (1986) COPD: a disease of reversible air-flow obstruction. Am Rev Respir Dis 133(5):725–726

    CAS  PubMed  Google Scholar 

  30. Perez-Padilla R, Hallal PC, Vazquez-Garcia JC, Muino A, Maquez M, Lopez MV, de Oca MM, Talamo C, Valdivia G, Pertuze J, Jardim J, Menezes AM (2007) Impact of bronchodilator use on the prevalence of COPD in population-based samples. COPD 4(2):113–120

    Article  PubMed  Google Scholar 

  31. Papi A, Romagnoli M, Baraldo S, Braccioni F, Guzzinati I, Saetta M, Ciaccia A, Fabbri LM (2000) Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162(5):1773–1777

    CAS  PubMed  Google Scholar 

  32. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12(2):121–127

    Article  CAS  PubMed  Google Scholar 

  33. Grumelli S, Corry DB, Song LZ, Song L, Green L, Huh J, Hacken J, Espada R, Bag R, Lewis DE, Kheradmand F (2004) An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 1(1):e8

    Article  PubMed  CAS  Google Scholar 

  34. Panina-Bordignon P, Papi A, Mariani M, Di Lucia P, Casoni G, Bellettato C, Buonsanti C, Miotto D, Mapp C, Villa A, Arrigoni G, Fabbri LM, Sinigaglia F (2001) The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest 107(11):1357–1364

    Article  CAS  PubMed  Google Scholar 

  35. Saetta M, Mariani M, Panina-Bordignon P, Turato G, Buonsanti C, Baraldo S, Bellettato CM, Papi A, Corbetta L, Zuin R, Sinigaglia F, Fabbri LM (2002) Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 165(10):1404–1409

    Article  PubMed  Google Scholar 

  36. Donnelly LE, Barnes PJ (2006) Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease. Trends Pharmacol Sci 27(10):546–553

    Article  CAS  PubMed  Google Scholar 

  37. Wang Z, Zheng T, Zhu Z, Homer RJ, Riese RJ, Chapman HA Jr, Shapiro SD, Elias JA (2000) Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med 192(11):1587–1600

    Article  CAS  PubMed  Google Scholar 

  38. Beeh KM, Kornmann O, Buhl R, Culpitt SV, Giembycz MA, Barnes PJ (2003) Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest 123(4):1240–1247

    Article  CAS  PubMed  Google Scholar 

  39. de Boer WI, Sont JK, van Schadewijk A, Stolk J, van Krieken JH, Hiemstra PS (2000) Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J Pathol 190(5):619–626

    Article  PubMed  Google Scholar 

  40. Maus UA, Koay MA, Delbeck T, Mack M, Ermert M, Ermert L, Blackwell TS, Christman JW, Schlondorff D, Seeger W, Lohmeyer J (2002) Role of resident alveolar macrophages in leukocyte traffic into the alveolar air space of intact mice. Am J Physiol Lung Cell Mol Physiol 282(6):L1245–L1252

    CAS  PubMed  Google Scholar 

  41. Hunninghake GW, Davidson JM, Rennard S, Szapiel S, Gadek JE, Crystal RG (1981) Elastin fragments attract macrophage precursors to diseased sites in pulmonary emphysema. Science 212(4497):925–927

    Article  CAS  PubMed  Google Scholar 

  42. Demedts IK, Bracke KR, Van Pottelberge G, Testelmans D, Verleden GM, Vermassen FE, Joos GF, Brusselle GG (2007) Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175(10):998–1005

    Article  CAS  PubMed  Google Scholar 

  43. Mukhopadhyay S, Hoidal JR, Mukherjee TK (2006) Role of TNFalpha in pulmonary pathophysiology. Respir Res 7:125

    Article  PubMed  CAS  Google Scholar 

  44. Sibille Y, Reynolds HY (1990) Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 141(2):471–501

    CAS  PubMed  Google Scholar 

  45. Hunninghake GW, Crystal RG (1983) Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis 128(5):833–838

    CAS  PubMed  Google Scholar 

  46. La Rocca G, Anzalone R, Magno F, Farina F, Cappello F, Zummo G (2007) Cigarette smoke exposure inhibits extracellular MMP-2 (gelatinase A) activity in human lung fibroblasts. Respir Res 8:23

    Article  PubMed  CAS  Google Scholar 

  47. Atkinson JJ, Senior RM (2003) Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 28(1):12–24

    Article  CAS  PubMed  Google Scholar 

  48. Ohnishi K, Takagi M, Kurokawa Y, Satomi S, Konttinen YT (1998) Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest 78(9):1077–1087

    CAS  PubMed  Google Scholar 

  49. Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G (2000) Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 96(8):2673–2681

    PubMed  Google Scholar 

  50. Peltoniemi MJ, Rytila PH, Harju TH, Soini YM, Salmenkivi KM, Ruddock LW, Kinnula VL (2006) Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease. Respir Res 7:133

    Article  PubMed  CAS  Google Scholar 

  51. MacNee W, Rahman I (2001) Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease? Trends Mol Med 7(2):55–62

    Article  CAS  PubMed  Google Scholar 

  52. Hegab AE, Sakamoto T, Nomura A, Ishii Y, Morishima Y, Iizuka T, Kiwamoto T, Matsuno Y, Homma S, Sekizawa K (2007) Niflumic acid and AG-1478 reduce cigarette smoke-induced mucin synthesis: the role of hCLCA1. Chest 131(4):1149–1156

    Article  CAS  PubMed  Google Scholar 

  53. Takeyama K, Jung B, Shim JJ, Burgel PR, Dao-Pick T, Ueki IF, Protin U, Kroschel P, Nadel JA (2001) Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol Lung Cell Mol Physiol 280(1):L165–L172

    CAS  PubMed  Google Scholar 

  54. Lemjabbar H, Li D, Gallup M, Sidhu S, Drori E, Basbaum C (2003) Tobacco smoke-induced lung cell proliferation mediated by tumor necrosis factor alpha-converting enzyme and amphiregulin. J Biol Chem 278(28):26202–26207

    Article  CAS  PubMed  Google Scholar 

  55. Nishikawa M, Kakemizu N, Ito T, Kudo M, Kaneko T, Suzuki M, Udaka N, Ikeda H, Okubo T (1999) Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-kappaB activation and IL-8 mRNA expression in guinea pigs in vivo. Am J Respir Cell Mol Biol 20(2):189–198

    CAS  PubMed  Google Scholar 

  56. Saetta M, Turato G, Facchini FM, Corbino L, Lucchini RE, Casoni G, Maestrelli P, Mapp CE, Ciaccia A, Fabbri LM (1997) Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. Am J Respir Crit Care Med 156(5):1633–1639

    CAS  PubMed  Google Scholar 

  57. Takeyama K, Agusti C, Ueki I, Lausier J, Cardell LO, Nadel JA (1998) Neutrophil-dependent goblet cell degranulation: role of membrane-bound elastase and adhesion molecules. Am J Physiol 275(2 Pt 1):L294–L302

    CAS  PubMed  Google Scholar 

  58. Sommerhoff CP, Nadel JA, Basbaum CB, Caughey GH (1990) Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J Clin Invest 85(3):682–689

    Article  CAS  PubMed  Google Scholar 

  59. Owen CA, Campbell MA, Sannes PL, Boukedes SS, Campbell EJ (1995) Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J Cell Biol 131(3):775–789

    Article  CAS  PubMed  Google Scholar 

  60. Tokuyama K, Kuo HP, Rohde JA, Barnes PJ, Rogers DF (1990) Neural control of goblet cell secretion in guinea pig airways. Am J Physiol 259(2 Pt 1):L108–L115

    CAS  PubMed  Google Scholar 

  61. Nadel JA (2000) Role of neutrophil elastase in hypersecretion during COPD exacerbations, and proposed therapies. Chest 117(5 Suppl 2):386S–389S

    Article  CAS  PubMed  Google Scholar 

  62. Liles WC, Dale DC, Price TH, Gaviria JM, Turner T, Saoud J, Frumkin LR (2000) Inhibition of in vivo neutrophil transmigration by a novel humanized anti-CD11/CD18 monoclonal antibody. Cytokines Cell Mol Ther 6(3):121–126

    CAS  PubMed  Google Scholar 

  63. Gan WQ, Man SF, Senthilselvan A, Sin DD (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59(7):574–580

    Article  CAS  PubMed  Google Scholar 

  64. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM (2006) Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61(1):17–22

    Article  CAS  PubMed  Google Scholar 

  65. Creutzberg EC, Schols AM, Weling-Scheepers CA, Buurman WA, Wouters EF (2000) Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161(3 Pt 1):745–752

    CAS  PubMed  Google Scholar 

  66. Pinto-Plata VM, Mullerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, Celli BR (2006) C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 61(1):23–28

    Article  CAS  PubMed  Google Scholar 

  67. Hersh CP, Miller DT, Kwiatkowski DJ, Silverman EK (2006) Genetic determinants of C-reactive protein in COPD. Eur Respir J 28(6):1156–1162

    Article  CAS  PubMed  Google Scholar 

  68. Yende S, Waterer GW, Tolley EA, Newman AB, Bauer DC, Taaffe DR, Jensen R, Crapo R, Rubin S, Nevitt M, Simonsick EM, Satterfield S, Harris T, Kritchevsky SB (2006) Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 61(1):10–16

    Article  CAS  PubMed  Google Scholar 

  69. Hurst JR, Donaldson GC, Perera WR, Wilkinson TM, Bilello JA, Hagan GW, Vessey RS, Wedzicha JA (2006) Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 174(8):867–874

    Article  CAS  PubMed  Google Scholar 

  70. Sauleda J, Garcia-Palmer FJ, Gonzalez G, Palou A, Agusti AG (2000) The activity of cytochrome oxidase is increased in circulating lymphocytes of patients with chronic obstructive pulmonary disease, asthma, and chronic arthritis. Am J Respir Crit Care Med 161(1):32–35

    CAS  PubMed  Google Scholar 

  71. Eid AA, Ionescu AA, Nixon LS, Lewis-Jenkins V, Matthews SB, Griffiths TL, Shale DJ (2001) Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164(8 Pt 1):1414–1418

    CAS  PubMed  Google Scholar 

  72. Takabatake N, Nakamura H, Abe S, Inoue S, Hino T, Saito H, Yuki H, Kato S, Tomoike H (2000) The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161(4 Pt 1):1179–1184

    CAS  PubMed  Google Scholar 

  73. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL (2001) Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103(16):2055–2059

    CAS  PubMed  Google Scholar 

  74. Coletta AP, Clark AL, Banarjee P, Cleland JG (2002) Clinical trials update: renewal (renaissance and recover) and attach. Eur J Heart Fail 4(4):559–561

    Article  CAS  PubMed  Google Scholar 

  75. de Jong JW, van der Belt-Gritter B, Koeter GH, Postma DS (1997) Peripheral blood lymphocyte cell subsets in subjects with chronic obstructive pulmonary disease: association with smoking, IgE and lung function. Respir Med 91(2):67–76

    Article  PubMed  Google Scholar 

  76. Domagala-Kulawik J, Hoser G, Dabrowska M, Chazan R (2007) Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD. Respir Med 101(6):1338–1343

    Article  PubMed  Google Scholar 

  77. Glader P, von Wachenfeldt K, Lofdahl CG (2006) Systemic CD4+ T-cell activation is correlated with FEV1 in smokers. Respir Med 100(6):1088–1093

    Article  PubMed  Google Scholar 

  78. Kim WD, Kim WS, Koh Y, Lee SD, Lim CM, Kim DS, Cho YJ (2002) Abnormal peripheral blood T-lymphocyte subsets in a subgroup of patients with COPD. Chest 122(2):437–444

    Article  PubMed  Google Scholar 

  79. Koch A, Gaczkowski M, Sturton G, Staib P, Schinkothe T, Klein E, Rubbert A, Bacon K, Wassermann K, Erdmann E (2007) Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking. Eur Respir J 29(1):42–50

    Article  CAS  PubMed  Google Scholar 

  80. Mannino DM, Watt G, Hole D, Gillis C, Hart C, McConnachie A, Davey Smith G, Upton M, Hawthorne V, Sin DD, Man SF, Van Eeden S, Mapel DW, Vestbo J (2006) The natural history of chronic obstructive pulmonary disease. Eur Respir J 27(3):627–643

    Article  CAS  PubMed  Google Scholar 

  81. Holguin F, Folch E, Redd SC, Mannino DM (2005) Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 128(4):2005–2011

    Article  PubMed  Google Scholar 

  82. Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD (2005) COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanent Medical Care Program. Chest 128(4):2068–2075

    Article  PubMed  Google Scholar 

  83. Sin DD, Wu L, Anderson JA, Anthonisen NR, Buist AS, Burge PS, Calverley PM, Connett JE, Lindmark B, Pauwels RA, Postma DS, Soriano JB, Szafranski W, Vestbo J (2005) Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 60(12):992–997, Epub 2005 Oct 14

    Article  CAS  PubMed  Google Scholar 

  84. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539–545

    Article  CAS  PubMed  Google Scholar 

  85. Naeije R (2005) Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2(1):20–22

    Article  PubMed  Google Scholar 

  86. Naeije R, Vizza D (2005) Current perspectives modern hemodynamic evaluation of the pulmonary circulation. Application to pulmonary arterial hypertension and embolic pulmonary hypertension. Ital Heart J 6(10):784–788

    PubMed  Google Scholar 

  87. Le Jemtel TH, Padeletti M, Jelic S (2007) Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 49(2):171–180

    Article  PubMed  Google Scholar 

  88. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM (1996) Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. Bmj 313(7059):711–715, discussion 715–6

    CAS  PubMed  Google Scholar 

  89. Sin DD, Man SF (2003) Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107(11):1514–1519

    Article  PubMed  Google Scholar 

  90. Rana JS, Mittleman MA, Sheikh J, Hu FB, Manson JE, Colditz GA, Speizer FE, Barr RG, Camargo CA Jr (2004) Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diab Care 27(10):2478–2484

    Article  Google Scholar 

  91. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, Tracy RP (2001) The relation of markers of inflammation to the development of glucose disorders in the elderly: the cardiovascular health study. Diabetes 50(10):2384–2389

    Article  CAS  PubMed  Google Scholar 

  92. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G (1999) Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis risk in communities study): a cohort study. Lancet 353(9165):1649–1652

    Article  CAS  PubMed  Google Scholar 

  93. Pickup JC, Mattock MB, Chusney GD, Burt D (1997) NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40(11):1286–1292

    Article  CAS  PubMed  Google Scholar 

  94. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB (2004) Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351(25):2599–2610

    Article  CAS  PubMed  Google Scholar 

  95. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347(20):1557–1565

    Article  CAS  PubMed  Google Scholar 

  96. Sonnenberg GE, Krakower GR, Kissebah AH (2004) A novel pathway to the manifestations of metabolic syndrome. Obes Res 12(2):180–186

    Article  CAS  PubMed  Google Scholar 

  97. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271(5249):665–668

    Article  CAS  PubMed  Google Scholar 

  98. Porter MH, Cutchins A, Fine JB, Bai Y, DiGirolamo M (2002) Effects of TNF-alpha on glucose metabolism and lipolysis in adipose tissue and isolated fat-cell preparations. J Lab Clin Med 139(3):140–146

    Article  CAS  PubMed  Google Scholar 

  99. Zinman B, Hanley AJ, Harris SB, Kwan J, Fantus IG (1999) Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab 84(1):272–278

    Article  CAS  PubMed  Google Scholar 

  100. Tamakoshi K, Yatsuya H, Kondo T, Hori Y, Ishikawa M, Zhang H, Murata C, Otsuka R, Zhu S, Toyoshima H (2003) The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord 27(4):443–449

    Article  CAS  PubMed  Google Scholar 

  101. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86(5):1930–1935

    Article  CAS  PubMed  Google Scholar 

  102. Albert MA (2000) The role of C-reactive protein in cardiovascular disease risk. Curr Cardiol Rep 2(4):274–279

    Article  CAS  PubMed  Google Scholar 

  103. Ballou SP, Lozanski G (1992) Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 4(5):361–368

    Article  CAS  PubMed  Google Scholar 

  104. Zahedi K, Tebo JM, Siripont J, Klimo GF, Mortensen RF (1989) Binding of human C-reactive protein to mouse macrophages is mediated by distinct receptors. J Immunol 142(7):2384–2392

    CAS  PubMed  Google Scholar 

  105. Devaraj S, Du Clos TW, Jialal I (2005) Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol 25(7):1359–1363

    Article  CAS  PubMed  Google Scholar 

  106. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P (2004) Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351(25):2611–2618

    Article  CAS  PubMed  Google Scholar 

  107. Stockley RA, ÓBrien C, Pye A, Hill SL (2000) Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 117(6):1638–1645

    Article  CAS  PubMed  Google Scholar 

  108. Wedzicha JA, Seemungal TA, MacCallum PK, Paul EA, Donaldson GC, Bhowmik A, Jeffries DJ, Meade TW (2000) Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost 84(2):210–215

    CAS  PubMed  Google Scholar 

  109. Almagro P, Calbo E, Ochoa de Echaguen A, Barreiro B, Quintana S, Heredia JL, Garau J (2002) Mortality after hospitalization for COPD. Chest 121(5):1441–1448

    Article  PubMed  Google Scholar 

  110. McEvoy CE, Ensrud KE, Bender E, Genant HK, Yu W, Griffith JM, Niewoehner DE (1998) Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157(3 Pt 1):704–709

    CAS  PubMed  Google Scholar 

  111. Gianni W, Ricci A, Gazzaniga P, Brama M, Pietropaolo M, Votano S, Patane F, Agliano AM, Spera G, Marigliano V, Ammendola S, Agnusdei D, Migliaccio S, Scandurra R (2004) Raloxifene modulates interleukin-6 and tumor necrosis factor-alpha synthesis in vivo: results from a pilot clinical study. J Clin Endocrinol Metab 89(12):6097–6099

    Article  CAS  PubMed  Google Scholar 

  112. Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, Pacifici R (2000) Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 106(10):1229–1237

    Article  CAS  PubMed  Google Scholar 

  113. Kudo O, Sabokbar A, Pocock A, Itonaga I, Fujikawa Y, Athanasou NA (2003) Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 32(1):1–7

    Article  CAS  PubMed  Google Scholar 

  114. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402(6759):304–309

    Article  CAS  PubMed  Google Scholar 

  115. Teng YT, Nguyen H, Gao X, Kong YY, Gorczynski RM, Singh B, Ellen RP, Penninger JM (2000) Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 106(6):R59–R67

    CAS  PubMed  Google Scholar 

  116. Couillard A, Prefaut C (2005) From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Respir J 26(4):703–719

    Article  CAS  PubMed  Google Scholar 

  117. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350(10):1005–1012

    Article  CAS  PubMed  Google Scholar 

  118. Schols AM, Slangen J, Volovics L, Wouters EF (1998) Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157(6 Pt 1):1791–1797

    CAS  PubMed  Google Scholar 

  119. Engelen MP, Schols AM, Lamers RJ, Wouters EF (1999) Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clin Nutr 18(5):275–280

    Article  CAS  PubMed  Google Scholar 

  120. Schols AM (2003) Nutritional and metabolic modulation in chronic obstructive pulmonary disease management. Eur Respir J Suppl 46:81s–86s

    Article  CAS  PubMed  Google Scholar 

  121. Baarends EM, Schols AM, Westerterp KR, Wouters EF (1997) Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD. Thorax 52(9):780–785

    Article  CAS  PubMed  Google Scholar 

  122. Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF (1996) Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 51(8):819–824

    Article  CAS  PubMed  Google Scholar 

  123. Kotler DP (2000) Cachexia. Ann Intern Med 133(8):622–634

    CAS  PubMed  Google Scholar 

  124. Morrison WL, Gibson JN, Scrimgeour C, Rennie MJ (1988) Muscle wasting in emphysema. Clin Sci (Lond) 75(4):415–420

    CAS  Google Scholar 

  125. Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF (1995) Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 152(4 Pt 1):1268–1274

    CAS  PubMed  Google Scholar 

  126. Tisdale MJ (1997) Biology of cachexia. J Natl Cancer Inst 89(23):1763–1773

    Article  CAS  PubMed  Google Scholar 

  127. Debigare R, Cote CH, Maltais F (2001) Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms. Am J Respir Crit Care Med 164(9):1712–1717

    CAS  PubMed  Google Scholar 

  128. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA, Coats AJ (1997) Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349(9058):1050–1053

    Article  CAS  PubMed  Google Scholar 

  129. Stewart CE, Newcomb PV, Holly JM (2004) Multifaceted roles of TNF-alpha in myoblast destruction: a multitude of signal transduction pathways. J Cell Physiol 198(2):237–247

    Article  CAS  PubMed  Google Scholar 

  130. Reid MB, Li YP (2001) Tumor necrosis factor-alpha and muscle wasting: a cellular perspective. Respir Res 2(5):269–272

    Article  CAS  PubMed  Google Scholar 

  131. Gordon JN, Green SR, Goggin PM (2005) Cancer cachexia. Qjm 98(11):779–788

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank M. McKenney for scientific assistance with the manuscript, and E. Veratelli for her scientific secretarial assistance.

Author information

Authors and Affiliations

  1. Department of Respiratory Diseases, University of Modena and Reggio Emilia, Modena, Italy

    Leonardo M. Fabbri & Fabrizio Luppi

  2. Department of Cardiologic, Thoracic and Vascular Sciences, University of Padova, Padova, Italy

    Bianca Beghe

  3. Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands

    Klaus F. Rabe

Authors
  1. Leonardo M. Fabbri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fabrizio Luppi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bianca Beghe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Klaus F. Rabe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. , Section of Pulmonary and Critical Care M, Baylor College of Medicine, 1504 Taub Loop, Houston, 77030, Texas, USA

    Nicola A. Hanania

  2. Michael E. DeBakey VA Medical Center, Baylor College of Medicine, 2002 Holcombe Blvd., Houston, 77030, Texas, USA

    Amir Sharafkhaneh

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Fabbri, L.M., Luppi, F., Beghe, B., Rabe, K.F. (2011). The Multiple Components of COPD. In: Hanania, N., Sharafkhaneh, A. (eds) COPD. Respiratory Medicine. Humana Press. https://doi.org/10.1007/978-1-59745-357-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-357-8_1

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-949-9

  • Online ISBN: 978-1-59745-357-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation